Skip to content

A Patient-Partnered, Pan-Canadian, Comparative Effectiveness Evaluation of an Acute Pediatric Mental Health and Addiction Care Bundle

Pediatrics | Mental Health | Mental Disorders | Emergency Psychiatric

The investigators will determine, in an 8-site, hybrid Type 1 cluster randomized effectiveness implementation trial, if an acute mental health care bundle, compared to standard care, improves wellbeing at 30 days in children and youth seeking emergency department care for mental health and substance use concerns.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    8 to 17

Critères de participation

Inclusion Criteria:

1. Age 8 to 17.99 years
2. Chief triage concern of at least one of the following (or comparable) mental health CEDIS triage categories:

1. Anxiety/situational crisis and/or hyperventilation
2. Bizarre/paranoid behaviour
3. Concern for patient's welfare
4. Depression/suicidal/deliberate self-harm
5. Hallucinations/delusions
6. Violent/homicidal behaviour
7. Insomnia
8. Pediatric disruptive behaviour

Exclusion Criteria:

1. Brought to the ED under provincial mental health legislation
2. Exhibiting features of schizophrenia, schizotypal, delusional disorders, or psychosis (e.g., hallucinations/delusions complaint should be reviewed carefully for this exclusion criterion)
3. Significant self-harm act (i.e., suicide attempt requiring medical clearance, excluding ideation or minor superficial wounds; e.g., laceration/puncture, overdose ingestion, etc.)
4. Other co-morbid medical concerns requiring oversight and/or medical clearance from an emergency physician (e.g., confusion/disorientation, substance withdrawal, other medical complaints, etc.)
5. Substance misuse/intoxication or altered level of consciousness
6. Exhibiting a behavioural syndrome associated with physiologic disturbances (e.g., anorexia)

Children/youth will also be excluded based on language barriers:
7. Language barrier (i.e., patient and parent/legal guardian must be fluent in either English or French)

Lieu de l'étude

Janeway Children's Hospital
Janeway Children's Hospital
Saint John's, Newfoundland and Labrador
Canada

Contactez l'équipe d'étude

Primary Contact

Robert Porter, MD

[email protected]
709-777-4239
The Hospital for Sick Children
The Hospital for Sick Children
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Yaron Finkelstein, MD

[email protected]
416-813-5317
London Health Sciences Centre
London Health Sciences Centre
London, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Gary Joubert, MD

[email protected]
519-685-8500
The Children's Hospital of Winnipeg
The Children's Hospital of Winnipeg
Winnipeg, Manitoba
Canada

Contactez l'équipe d'étude

Primary Contact

Scott Sawyer, MD

[email protected]
204-787-2433
IWK Health Centre
IWK Health Centre
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Primary Contact

Jonathan Cherry, MD

[email protected]
902-470-8003
Montreal Children's Hospital
Montreal Children's Hospital
Montréal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Laurie Plotnick, MD

[email protected]
514-412-4499
McMaster Children's Hospital
McMaster Children's Hospital
Hamilton, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Mohamed Eltorki, MD

[email protected]
905-521-2100
Jim Pattison Children's Hospital
Jim Pattison Children's Hospital
Saskatoon, Saskatchewan
Canada

Contactez l'équipe d'étude

Primary Contact

Ahmed Mater, MD

[email protected]
306-655-2965
Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: NCT04902391